Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Sponsor: Stanford University
Terminated
Business decision
Other terminated trials from Stanford University
Other Lung Cancer trials with similar outcome
This NA trial investigates Lung Cancer and Lung Cancer Non-Small Cell Cancer (NSCLC) and is currently terminated or withdrawn. Stanford University leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Feb 2020 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Jul 2017 — May 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting NA
First recorded
Aug 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .